US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 372.890
  • +5.530+1.51%
Close Nov 22 16:00 ET
  • 372.890
  • 0.0000.00%
Post 16:48 ET
16.65BMarket Cap16.38P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
22.89%748.9M
19.85%714.9M
33.70%677.7M
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
14.88%1.94B
18.38%491.5M
Operating revenue
22.89%748.9M
19.85%714.9M
33.70%677.7M
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
14.88%1.94B
18.38%491.5M
Cost of revenue
18.54%83.1M
21.37%77.8M
39.39%72.9M
69.85%257.5M
20.75%71M
88.44%70.1M
115.82%64.1M
101.93%52.3M
23.76%151.6M
69.94%58.8M
Gross profit
23.46%665.8M
19.67%637.1M
33.04%604.8M
15.99%2.07B
25.65%543.7M
12.64%539.3M
21.77%532.4M
4.27%454.6M
14.18%1.78B
13.69%432.7M
Operating expense
21.34%257.6M
44.84%317.2M
46.00%248.5M
9.95%885.1M
10.31%283.6M
29.06%212.3M
-6.97%219M
15.00%170.2M
-20.07%805M
21.96%257.1M
Selling and administrative expenses
20.77%154.1M
36.62%177.6M
65.41%144.4M
-1.04%477.1M
-19.00%132.2M
29.67%127.6M
-8.13%130M
10.51%87.3M
3.23%482.1M
27.60%163.2M
-Selling and marketing expense
0.00%20.7M
26.37%25.4M
37.28%23.2M
15.54%81.8M
4.78%24.1M
20.35%20.7M
24.84%20.1M
16.55%16.9M
9.94%70.8M
40.24%23M
-General and administrative expense
24.79%133.4M
38.49%152.2M
72.16%121.2M
-3.89%395.3M
-22.90%108.1M
31.65%106.9M
-12.36%109.9M
9.15%70.4M
2.16%411.3M
25.74%140.2M
Research and development costs
22.20%103.5M
56.85%139.6M
25.57%104.1M
26.35%408M
61.24%151.4M
28.14%84.7M
-5.22%89M
20.14%82.9M
-40.21%322.9M
13.27%93.9M
Operating profit
24.83%408.2M
2.07%319.9M
25.28%356.3M
20.95%1.18B
48.12%260.1M
4.04%327M
55.30%313.4M
-1.25%284.4M
76.24%979.7M
3.42%175.6M
Net non-operating interest income expense
33.67%39.7M
54.46%34.6M
162.99%40.5M
707.81%103.4M
322.35%35.9M
624.39%29.7M
3,633.33%22.4M
3,950.00%15.4M
773.68%12.8M
1,800.00%8.5M
Non-operating interest income
9.93%49.8M
24.19%46.2M
84.25%53.8M
259.96%162.7M
145.19%51M
240.60%45.3M
447.06%37.2M
579.07%29.2M
170.66%45.2M
395.24%20.8M
Non-operating interest expense
-35.26%10.1M
-21.62%11.6M
-3.62%13.3M
83.02%59.3M
22.76%15.1M
69.57%15.6M
138.71%14.8M
193.62%13.8M
74.19%32.4M
161.70%12.3M
Other net income (expense)
-1,110.20%-59.3M
233.33%800K
122.78%1.8M
66.59%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-137.44%-7.9M
-205.01%-41.9M
81.60%-5.3M
Special income (charges)
---65.1M
----
----
--0
--0
--0
----
----
26.09%-1.7M
--0
-Less:Other special charges
--65.1M
----
----
----
----
----
----
----
----
----
-Write off
----
----
----
--0
----
----
----
----
-26.09%1.7M
--0
Other non- operating income (expenses)
218.37%5.8M
233.33%800K
122.78%1.8M
65.17%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-134.65%-7.9M
-195.26%-40.2M
81.60%-5.3M
Income before tax
10.46%388.6M
6.00%355.3M
36.55%398.6M
34.05%1.27B
65.21%295.4M
12.58%351.8M
122.58%335.2M
-5.44%291.9M
60.06%950.6M
27.26%178.8M
Income tax
-5.58%79.5M
1.58%77.2M
80.39%92M
29.65%289.5M
67.67%78.3M
15.03%84.2M
119.65%76M
-25.87%51M
89.08%223.3M
65.02%46.7M
Net income
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
Net income continuous Operations
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
Minority interest income
Net income attributable to the parent company
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
Basic earnings per share
21.37%6.93
13.20%6.26
25.38%6.52
31.66%21.04
60.42%4.62
8.56%5.71
116.02%5.53
-2.07%5.2
50.75%15.98
15.66%2.88
Diluted earnings per share
18.77%6.39
11.64%5.85
26.95%6.17
32.07%19.81
63.30%4.36
9.57%5.38
117.43%5.24
-3.38%4.86
49.11%15
13.62%2.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 22.89%748.9M19.85%714.9M33.70%677.7M20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M14.88%1.94B18.38%491.5M
Operating revenue 22.89%748.9M19.85%714.9M33.70%677.7M20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M14.88%1.94B18.38%491.5M
Cost of revenue 18.54%83.1M21.37%77.8M39.39%72.9M69.85%257.5M20.75%71M88.44%70.1M115.82%64.1M101.93%52.3M23.76%151.6M69.94%58.8M
Gross profit 23.46%665.8M19.67%637.1M33.04%604.8M15.99%2.07B25.65%543.7M12.64%539.3M21.77%532.4M4.27%454.6M14.18%1.78B13.69%432.7M
Operating expense 21.34%257.6M44.84%317.2M46.00%248.5M9.95%885.1M10.31%283.6M29.06%212.3M-6.97%219M15.00%170.2M-20.07%805M21.96%257.1M
Selling and administrative expenses 20.77%154.1M36.62%177.6M65.41%144.4M-1.04%477.1M-19.00%132.2M29.67%127.6M-8.13%130M10.51%87.3M3.23%482.1M27.60%163.2M
-Selling and marketing expense 0.00%20.7M26.37%25.4M37.28%23.2M15.54%81.8M4.78%24.1M20.35%20.7M24.84%20.1M16.55%16.9M9.94%70.8M40.24%23M
-General and administrative expense 24.79%133.4M38.49%152.2M72.16%121.2M-3.89%395.3M-22.90%108.1M31.65%106.9M-12.36%109.9M9.15%70.4M2.16%411.3M25.74%140.2M
Research and development costs 22.20%103.5M56.85%139.6M25.57%104.1M26.35%408M61.24%151.4M28.14%84.7M-5.22%89M20.14%82.9M-40.21%322.9M13.27%93.9M
Operating profit 24.83%408.2M2.07%319.9M25.28%356.3M20.95%1.18B48.12%260.1M4.04%327M55.30%313.4M-1.25%284.4M76.24%979.7M3.42%175.6M
Net non-operating interest income expense 33.67%39.7M54.46%34.6M162.99%40.5M707.81%103.4M322.35%35.9M624.39%29.7M3,633.33%22.4M3,950.00%15.4M773.68%12.8M1,800.00%8.5M
Non-operating interest income 9.93%49.8M24.19%46.2M84.25%53.8M259.96%162.7M145.19%51M240.60%45.3M447.06%37.2M579.07%29.2M170.66%45.2M395.24%20.8M
Non-operating interest expense -35.26%10.1M-21.62%11.6M-3.62%13.3M83.02%59.3M22.76%15.1M69.57%15.6M138.71%14.8M193.62%13.8M74.19%32.4M161.70%12.3M
Other net income (expense) -1,110.20%-59.3M233.33%800K122.78%1.8M66.59%-14M88.68%-600K16.95%-4.9M98.84%-600K-137.44%-7.9M-205.01%-41.9M81.60%-5.3M
Special income (charges) ---65.1M----------0--0--0--------26.09%-1.7M--0
-Less:Other special charges --65.1M------------------------------------
-Write off --------------0-----------------26.09%1.7M--0
Other non- operating income (expenses) 218.37%5.8M233.33%800K122.78%1.8M65.17%-14M88.68%-600K16.95%-4.9M98.84%-600K-134.65%-7.9M-195.26%-40.2M81.60%-5.3M
Income before tax 10.46%388.6M6.00%355.3M36.55%398.6M34.05%1.27B65.21%295.4M12.58%351.8M122.58%335.2M-5.44%291.9M60.06%950.6M27.26%178.8M
Income tax -5.58%79.5M1.58%77.2M80.39%92M29.65%289.5M67.67%78.3M15.03%84.2M119.65%76M-25.87%51M89.08%223.3M65.02%46.7M
Net income 15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M
Net income continuous Operations 15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M
Minority interest income
Net income attributable to the parent company 15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M
Basic earnings per share 21.37%6.9313.20%6.2625.38%6.5231.66%21.0460.42%4.628.56%5.71116.02%5.53-2.07%5.250.75%15.9815.66%2.88
Diluted earnings per share 18.77%6.3911.64%5.8526.95%6.1732.07%19.8163.30%4.369.57%5.38117.43%5.24-3.38%4.8649.11%1513.62%2.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data